Treatment of cutaneous pseudolymphoma with interferon alfa-2b

Journal of the American Academy of Dermatology

Volumn 60, Issue 1, 2009, Pages 172-174

  Tomar, Sanjay ^a   Stoll, Howard L ^a,c   Grassi, Marcelle A ^a,c   Cheney, Richard ^b  

^a UNIVERSITY AT BUFFALO   (United States)

^b Department of Pathology ^*  (United States)

^c ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON; STEROID; TRIAMCINOLONE ACETONIDE;

AGED; ANAMNESIS; ARTICLE; CANCER IMMUNOTHERAPY; CASE REPORT; CELL AGGREGATION; CLINICAL FEATURE; DRUG SAFETY; FEMALE; HISTOPATHOLOGY; HUMAN; INJECTION SITE PAIN; LYMPHOCYTIC INFILTRATION; PRIORITY JOURNAL; PSEUDOLYMPHOMA; SKIN MANIFESTATION; SKIN PSEUDOLYMPHOMA; SKIN ULCER; STEROID THERAPY; SYSTEMIC DISEASE; TENDERNESS;

AGED; ANTINEOPLASTIC AGENTS; FEMALE; HUMANS; INTERFERON ALFA-2B; PSEUDOLYMPHOMA; SKIN DISEASES;

EID: 57649242610     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2008.07.052     Document Type: Article

References (5)

1. Ploysangam T., Breneman D.L., and Mutasim D.F. Cutaneous pseudolymphomas. J Am Acad Dermatol 38 (1998) 877-895
2. Lee M.W., Lee D.K., Choi J.H., Moon K.C., and Koh J.K. Clinicopathologic study of cutaneous pseudolymphomas. J Dermatol 32 (2005) 594-601
3. Stadler R., and Ruszczak Z. Interferons New addition and indications for use. Dermatol Clin 11 (1993) 187-199
4. Gailhofer G., Smolle J., Soyer H.P., and Kerl H. Alfa-interferon treatment of cutaneous pseudolymphoma-modulation of the dermal infilterate. J Invest Dermatol 90 (1988) 240
5. Bunn P.A., and Norris D.A. The therapeutic role of interferons and monoclonal antibodies in cutaneous T-cell lymphoma. J Invest Dermatol 95 (1990) 209-212